Energy & environment · 04/01/1995Updated: 10/18/2026 · 1 min read

Nuclear Regulatory Commission Amends Rule for Commercial Distribution of Radioactive Drugs

The Nuclear Regulatory Commission (NRC) is revising a rule to reduce regulatory burden and uncertainty for companies that manufacture and distribute radioactive drugs for medical use. The change follows reconsideration of requirements for labeling these products.